- Global Pharma News & Resources

Clinical Nutrition Market Size to Reach US $55.25 Billion at 5.3% CAGR Globally by 2026

Pune, Maharashtra, India, February 26 2021 (Wiredrelease) Allied Analytics –:Rise in prevalence of chronic disorders, surge in number of patients utilizing advanced clinical nutritional products, and increase in R&D investments by governments in the healthcare sector drive the growth of the global clinical nutrition market. However, lack of awareness and strict regulations restrain the market growth. On the other hand, advancements in clinical nutrition and untapped potential in emerging countries offer new opportunities in the coming years.

Clinical Nutrition Market by Route of Administration (Oral, Enteral, and Parenteral), Application (Cancer, Neurological Diseases, Gastrointestinal Disorders, Metabolic Disorders, and Others), and End User (Pediatric, Adults, and Geriatric): Global Opportunity Analysis and Industry Forecast, 2019–2026.” According to the report, the global clinical nutrition industry generated $31.35 billion in 2018, and is estimated to reach $55.25 billion by 2026, witnessing a CAGR of 5.3% from 2019 to 2026.  

Download Sample PDF Of Report@

COVID-19 Scenario:

– The governing authorities such as WHO, ESPEN, ASPEN, and others have released guidelines regarding nutritional assessment and screening of hospitalized Covid-19 patients.

– Nutrition therapy based on guidelines and recommendations by authorities has been carried out for all the patients. It involves determining the requirement of water, protein, and energy for the individuals and providing them in required quantities to ensure nutritional adequacy.

The oral segment to maintain its lead position by 2026

Based on route of administration, the oral segment contributed to nearly half of the total share of the global clinical nutrition market in 2018, and is projected to maintain its lead position in terms of revenue during the forecast period. In addition, this segment is expected to witness the largest CAGR of 5.8% from 2019 to 2026. This is due to its widespread usage in patients as it offers ease in intake and convenience for treatment of several diseases. The report also offers a detailed analysis of segments including enteral and parenteral.

The cancer segment to offer lucrative opportunities

Based on application, the cancer segment held the largest market share with nearly one-third of the global clinical nutrition market share in 2018, and would continue its lead during the forecast period. Moreover, this segment is projected to portray the highest CAGR of 6.0% from 2019 to 2026. This is attributed to the need to fulfill nutritional deficiency occurring in patients from various treatments such as hormone therapy, chemotherapy, radiation therapy, immunotherapy, and stem cell transplant. The research also discusses segments including neurological diseases, gastrointestinal disorders, metabolic disorders, and others.

North America to maintain its highest revenue contribution throughout the forecast period

Based on region, North America contributed to the largest share in terms of revenue in 2018, accounting for more than one-third of the total share of the global clinical nutrition market, and is estimated to maintain its highest contribution throughout the forecast period. This is due to rise in number of chronic disease including coronary artery disease, diabetes, ischemic stroke, and few cancer indications in the region. However, Asia-Pacific is expected to witness the fastest CAGR of 6.0% from 2019 to 2026, owing to rise in metabolic disorders and rise in patient awareness regarding adoption of clinical nutrition products.

For Purchase Enquiry at:

The report provides a comprehensive analysis of the key players operating in the global clinical nutrition market, which include Abbott Laboratories, B. Braun Melsungen AG, Danone Nutricia, Baxter International Inc., Fresenius SE & Co. KGaA, Perrigo Company Plc, Pfizer Inc, Nestlé S.A, Lonza Ltd, and Hero Nutritionals Inc. The other players in the value chain (companies not included in the report) include Ajinomoto Co. Inc., Gentiva Health Services Inc., Mead Johnson & Company, Kendall, and H. J. Heinz Company.

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This content has been published by Allied Analytics company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at

Editor Details

Last Updated: 26-Feb-2021